Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (161-170 of 247) with videos related to

Pageof 25
Sort By:
American Journal of Clinical Oncology|April 8, 2006
Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approachRobert I Haddad, Marshall R Posner, Paul M Busse, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 1999
An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignanciesR B Tishler, P M Busse, C M Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neckRobert I Haddad, Roy B Tishler, Charles Norris, et al.
The Oncologist|February 23, 2013
Trastuzumab for the treatment of salivary duct carcinomaSewanti A Limaye, Marshall R Posner, Jeffrey F Krane, et al.
The Laryngoscope|December 10, 2009
Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosisLaura A Goguen, Charles M Norris, Michael T Jaklitsch, et al.
Journal of Virology|April 3, 1998
Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulinsA Li, H Katinger, M R Posner, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1E J Wolfe, L A Cavacini, M H Samore, et al.
Cancer Epidemiology|August 13, 2016
Racial disparities in incidence of human papillomavirus-associated oropharyngeal cancer in an urban populationIlana Ramer, Indu Varier, David Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neckM R Posner, B Glisson, G Frenette, et al.
Cancer|June 24, 2010
Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancerDavid J Sher, Robert I Haddad, Charles M Norris, et al.
Pageof 25

Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|April 8, 2006
Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approachRobert I Haddad, Marshall R Posner, Paul M Busse, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 1999
An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignanciesR B Tishler, P M Busse, C M Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neckRobert I Haddad, Roy B Tishler, Charles Norris, et al.
The Oncologist|February 23, 2013
Trastuzumab for the treatment of salivary duct carcinomaSewanti A Limaye, Marshall R Posner, Jeffrey F Krane, et al.
The Laryngoscope|December 10, 2009
Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosisLaura A Goguen, Charles M Norris, Michael T Jaklitsch, et al.
Journal of Virology|April 3, 1998
Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulinsA Li, H Katinger, M R Posner, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1E J Wolfe, L A Cavacini, M H Samore, et al.
Cancer Epidemiology|August 13, 2016
Racial disparities in incidence of human papillomavirus-associated oropharyngeal cancer in an urban populationIlana Ramer, Indu Varier, David Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neckM R Posner, B Glisson, G Frenette, et al.
Cancer|June 24, 2010
Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancerDavid J Sher, Robert I Haddad, Charles M Norris, et al.
Pageof 25